Jula Inrig

EVP, Head of R&D & CMO, Travere Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$5.2M

Companies

Latest trade

Sep 15, 2026

Companies

Travere Therapeutics, Inc.EVP, Head of R&D & CMO −$5.2M

Trades

TVTX Sold 44,674 shares at $62.34 · planned $2.8M Sep 15

TVTX Sold 311 shares at $43.95 · planned $0.0M May 6

TVTX Sold 2,174 shares at $46.65 · planned $0.1M May 5

TVTX Sold 20,000 shares at $45.00 · planned $0.9M May 4

TVTX Sold 1,018 shares at $42.61 · planned $0.0M Apr 15

TVTX Sold 7,215 shares at $41.93 · planned $0.3M Apr 14

TVTX Sold 1,779 shares at $32.21 · planned $0.1M Feb 4

TVTX Sold 6,956 shares at $32.12 $0.2M Feb 3

TVTX Sold 445 shares at $37.75 · planned $0.0M Jan 6

TVTX Sold 2,031 shares at $40.18 · planned $0.1M Jan 5

TVTX Sold 15,000 shares at $42.00 · planned $0.6M Dec 24

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.